Introduction on IPC
Indian Pharmacopoeia (IP)-2010
Indian Pharmacopoeia [IP]
Composition of the Commission
Chairperson IPC - Message
Secretary-cum-Scientific Director - Outlook
Rules and Regulations of the IPC
IP Reference Spectra
Reference Substances [IPRS]
Notices and IP Compliance
Common Queries on IP
National Formulary of India [NFI]
Indian Pharmacopoeia Laboratory (IPL)
Memorable Events
Tender Documents
RTI Act 2005
Careers
Contact Us
News
Articles
shoppingcart
fr   Products
fr   Login
aw
q National Formulary of India [NFI]
 

The National Formulary of India is essentially meant for the guidance of the members of the medical profession; medical students, nurses and pharmacists working in hospitals and in sales establishments. In the preparation of this Formulary, the expert opinion of medical practitioners, teachers in medicine, nurses, pharmacists and Pharmaceutical manufacturers has been obtained. The selection of drugs for inclusion in the National Formulary has been made taking into consideration the relative advantages and disadvantages of the various drugs used, the extent of their use in current medical practice and their availability in the country. Thus the National Formulary of India represents a broad consensus of medical opinion in respect of drugs and their formulations and provides the physician with carefully selected therapeutic agents of proved effectiveness which form the basis of national drug therapy.

 

As more than three decades have elapsed since the publication of the last edition of the National Formulary of India, it is to be expected that there would be a large number of additions and consequent deletions.  The experts are working to publish the pre-print version of the 4th edition of NFI by end of July 2010. This edition would have many distinct features to promote the rational use of medicines in the country.

 

The formulations included in the Formulary and the ingredients thereof should conform to the standards laid down in the current edition of the Indian Pharmacopoeia. If no standards are specified in the current edition but are specified in the immediately preceding edition of the Indian Pharmacopoeia then these standards would apply. In respect of drugs for which no standards have been laid down in the Indian Pharmacopoeia, these would have to conform to the standards laid down in the official pharmacopoeia of any other country wherein they are included. The provisions of the Drugs and Cosmetics Act and the Rules made thereunder including those relating to labelling and conditions of storage should be observed.

head  
Expert Committee meet on Radio-Pharmaceuticals
IPC-USP Meeting
IPC has been certified for ISO 9001: 2008
IP 2010 Released
Foundation Day of the IPC
Brief outcome of the 20th Scientific Body Meeting
Dr Sibu Chakrabarti Eminent Technocrat USA visited
NFI Review Meeting
IDMA-IPC-USP 9th ASM
Wi-Fi internet hasbeen installed in the IPC Campus
Scientific Body Member’s Comment on IP 2010
New edition of NFI to be out after 31 years
Coming event
Visit of Dr. Lalji Singh - Bhatnagar Fellow - CSIR
 
qw
  Site Best Viewed in 1024x768 Resolution
Designed and Developed by NIC/NICSI